Close Menu

NEW YORK (GenomeWeb) – The New York State Department of Health has approved Columbia University Medical Center's 467-gene targeted sequencing cancer test, the university said today.

Columbia runs its test on the Illumina HiSeq 2500 out of its CLIA-certified, CAP-accredited Laboratory of Personalized Genomic Medicine. It will run the test on fresh or frozen tissue samples, as well as formalin-fixed paraffin-embedded tissue.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Jun
02
Sponsored by
NanoString

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.